A new version of the once-popular asthma inhaler Primatene Mist will soon return to U.S. stores.The Food and Drug Administration approved the over-the-counter aerosol inhaler late Wednesday. It’s for temporary relief of mild, intermittent asthma symptoms in people ages 12 and up. This undated product image provided by Amphastar shows Primatene Mist. A new version...
Tag: <span>Asthma</span>
Pathway to resolve allergic asthma is discovered
A group of Brazilian researchers succeeded in preventing allergic asthma from progressing in experimental models by increasing the amount of a protein. This increase, in turn, blocked the CD4+ T lymphocytes responsible for producing a cytokine that triggers a cascade of events resulting in the onset and progression of the disease. This knowledge of how...
A couple of fishy meals a week may keep the asthma away
Omega-3 fatty acids have been shown to reduce inflammation, and asthma involves an inflammation of the airways. Would eating omega-3-rich fish therefore help reduce the severity of asthma? A new study indicates that the answer is likely Yes. Image: Eating plenty of fatty fish could help minimize asthma symptoms(Credit:svariophoto/Depositphotos) Led by registered dietician Maria Papamichael from Australia’s La Trobe University,...
Protein found in patients with severe asthma can help identify who would benefit from targeted drugs
In a novel study, researchers succeeded in identifying patients with a form of severe asthma (type 2 endotype) by measuring periostin concentrations in their airways. These patients with the type 2 (T2) endotype may benefit from newly developed targeted treatments that have the potential to transform their quality of life, report researchers in the journal...
Have asthma and a pet? Re-homing your cat or dog may not be necessary
AMERICAN COLLEGE OF CHEST PHYSICIANS A study from the Nationwide Children’s Hospital analyzed environmental exposures, like a pet and secondhand smoke, to determine if they have a role in asthma control among children whose asthma is managed per NAEPP (EPR-3) guidelines. Researchers found that once asthma guidelines are followed, environmental exposures to pets or secondhand...
More than 40 percent of women with asthma may develop COPD, but risk may be reduced
AMERICAN THORACIC SOCIETY Aug.10, 2018–More than 4 in 10 women with asthma may go on to develop chronic obstructive pulmonary disease (COPD), according to a study conducted in Ontario, Canada, and published online in the Annals of the American Thoracic Society. IMAGE: MORE THAN 4 IN 10 WOMEN WITH ASTHMA MAY GO ON TO DEVELOP CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)....
Combination of LABA + inhaled glucocorticoid safe in asthma
(HealthDay)—Compared to treatment with an inhaled glucocorticoid alone, combination therapy with a long-acting β2-agonist (LABA) and an inhaled glucocorticoid is not associated with a significantly higher risk of serious asthma-related events, according to a study published online June 27 in the New England Journal of Medicine. William W. Busse, M.D., from the University of Wisconsin School...
Severe asthma: Eczema drug succeeds where others fail
Two new studies — one of which is a double-blind, randomized trial — show that the eczema drug dupilumab is safer and more effective than current therapies for treating severe asthma. Estimates suggest that up to 25 million people in the United States have asthma, and over 31 million have a form of eczema. The link between eczema, or atopic dermatitis,...
How parasitic worms could help us with everything from obesity to asthma
This parasitic worm, Heligmosomoides polygyrus, has been found to reduce incidences of obesity in mouse experiments A growing body of research is suggesting that parasitic worms could in fact have a positive effect on our immune system. A new study is bolstering that hypothesis, finding in animal experiments that a certain type of helminth infection can...
Stem cells could offer hope for patients with lung damage from COPD and asthma
Stem cell therapy could treat damaged lung cells (bottom right). Early stage trials have shown promise for a cell-based therapy for treating lung tissue damaged by respiratory diseases. In a collaboration between Imperial College London and Hong Kong University (HKU), scientists have shown that the stem cells can reduce some of the damage seen in human lung...